Middeke, J. M., & Klein, S. (2017). Long-term follow-up and impact of comorbidity before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: Lessons learned from the prospective BRIDGE Trial. Biology of blood and marrow transplantation, 23(9), . https://doi.org/10.1016/j.bbmt.2017.05.014
Chicago-Zitierstil (17. Ausg.)Middeke, Jan Moritz, und Stefan Klein. "Long-term Follow-up and Impact of Comorbidity Before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia: Lessons Learned from the Prospective BRIDGE Trial." Biology of Blood and Marrow Transplantation 23, no. 9 (2017). https://doi.org/10.1016/j.bbmt.2017.05.014.
MLA-Zitierstil (9. Ausg.)Middeke, Jan Moritz, und Stefan Klein. "Long-term Follow-up and Impact of Comorbidity Before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia: Lessons Learned from the Prospective BRIDGE Trial." Biology of Blood and Marrow Transplantation, vol. 23, no. 9, 2017, https://doi.org/10.1016/j.bbmt.2017.05.014.